Aspilets/Aspilets-EC Indications/Uses

For primary prevention of thromboembolic disorders and cardiovascular events: Ischemic stroke; Transient ischemic attack (TIA); Acute myocardial infarction (MI).
Aspilets: Prevention of recurrent MI; Unstable angina pectoris; Chronic stable angina pectoris.
For secondary prevention of cardiovascular disease in persons with diabetes mellitus especially in the following subgroups: History of myocardial infarction, vascular bypass procedure, stroke or transient ischemic attack, and angina.
Persons with additional risk factors: hypertension, smoking, dyslipidemia, and family history of cardiovascular disease.
Revascularization Procedures: For patients who have undergone revascularization procedures such as coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA), and carotid endarterectomy when there is a pre-existing condition for which aspirin is already indicated.
Pregnancy-Induced Hypertension: For primary prevention of pregnancy-induced hypertension, preeclampsia and intrauterine growth retardation particularly in pregnant women with pre-existing chronic hypertension, auto-immune disorders like systemic lupus erythematosus (SLE), positive anticardiolipin antibody test, history of recurring toxemia in successive pregnancies, and hypotension developing before the 20^th week of gestation.
Aspilets EC: For the prevention of cardiovascular disease: Encourage aspirin use in men (age 45 to 79 years old) and women (age 55 to 79 years old) when potential benefit (i.e., prevention of myocardial infarction in men and prevention of ischemic stroke in women) outweighs potential harm of gastrointestinal hemorrhage. (See Table 1.)

Click on icon to see table/diagram/image